Global
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
7,360.74%
|
Dec. 31, 2023 | USD 0.29 | 0.68% |
|
Sweden |
|
2 |
1,740.35%
|
Dec. 31, 2023 | USD 24.32 | -0.24% |
|
Germany |
|
3 |
248.33%
|
Dec. 31, 2023 | USD 0.41 | 1.78% |
|
Sweden |
|
4 |
235.45%
|
Dec. 31, 2023 | USD 1.01 | -1.50% |
|
Sweden |
|
5 |
201.72%
|
Dec. 31, 2023 | USD 0.20 | 2.06% |
|
Sweden |
|
6 |
177.80%
|
Sept. 30, 2024 | USD 6.52 | -5.10% |
|
United States |
|
7 |
151.08%
|
Dec. 31, 2023 | USD 0.23 | -0.87% |
|
Sweden |
|
8 |
136.49%
|
Dec. 31, 2023 | USD 2.16 | 6.70% |
|
France |
|
9 |
120.46%
|
Dec. 31, 2023 | USD 3.05 | 0.95% |
|
France |
|
10 |
114.29%
|
Sept. 30, 2024 | USD 2.73 | 10.08% |
|
United States |
|
11 |
113.38%
|
Dec. 31, 2023 | USD 0.84 | -0.17% |
|
Sweden |
|
12 |
110.01%
|
Dec. 31, 2023 | USD 0.62 | 4.32% |
|
China |
|
13 |
106.32%
|
Sept. 30, 2024 | USD 16.15 | -0.92% |
|
United States |
|
14 |
104.50%
|
Sept. 30, 2024 | USD 16.59 | -4.16% |
|
United States |
|
15 |
103.06%
|
Dec. 31, 2023 | USD 0.12 | -10.06% |
|
Sweden |
|
16 |
100.13%
|
Dec. 31, 2023 | USD 2.29 | 4.37% |
|
France |
|
17 |
100.01%
|
June 30, 2024 | USD 8.43 | 2.18% |
|
United States |
|
18 |
100.00%
|
Sept. 30, 2024 | USD 7.09 | 6.47% |
|
Japan |
|
19 |
100.00%
|
Sept. 30, 2024 | USD 2.84 | -3.07% |
|
United States |
|
20 |
100.00%
|
Dec. 31, 2023 | USD 3.98 | 0.01% |
|
Denmark |
|
21 |
100.00%
|
Dec. 31, 2023 | USD 0.25 | 1.09% |
|
||
22 |
100.00%
|
Dec. 31, 2023 | USD 4.09 | 5.18% |
|
||
23 |
100.00%
|
Dec. 31, 2023 | USD 0.10 | 0.68% |
|
Sweden |
|
24 |
100.00%
|
Dec. 31, 2023 | USD 14.84 | -2.75% |
|
United Kingdom |
|
25 |
100.00%
|
Dec. 31, 2023 | USD 1.17 | -3.73% |
|
Sweden |
|
26 |
100.00%
|
Dec. 31, 2023 | USD 0.20 | 0.09% |
|
United Kingdom |
|
27 |
100.00%
|
Sept. 30, 2024 | USD 3.20 | -5.88% |
|
United States |
|
28 |
100.00%
|
Dec. 31, 2023 | USD 1.96 | -0.51% |
|
Canada |
|
29 |
100.00%
|
Dec. 31, 2023 | USD 43.58 | 0.94% |
|
Israel |
|
30 |
100.00%
|
Dec. 31, 2023 | USD 0.01 | 0.04% |
|
Israel |
|
31 |
100.00%
|
Dec. 31, 2023 | USD 1.60 | -3.36% |
|
||
32 |
100.00%
|
Dec. 31, 2023 | USD 0.19 | 1.64% |
|
Israel |
|
33 |
100.00%
|
Dec. 31, 2023 | USD 39.01 | -3.56% |
|
Netherlands |
|
34 |
100.00%
|
June 30, 2024 | USD 10.29 | 0.14% |
|
Singapore |
|
35 |
100.00%
|
Dec. 31, 2023 | USD 23.67 | -3.70% |
|
Netherlands |
|
36 |
100.00%
|
June 30, 2024 | USD 1.65 | 0.61% |
|
United States |
|
37 |
100.00%
|
Dec. 31, 2023 | USD 1.00 | -0.06% |
|
China |
|
38 |
100.00%
|
Dec. 31, 2023 | USD 0.95 | 0.80% |
|
United Kingdom |
|
39 |
100.00%
|
Dec. 31, 2023 | USD 2.77 | -7.67% |
|
Canada |
|
40 |
100.00%
|
Dec. 31, 2023 | USD 1.69 | 1.00% |
|
Israel |
|
41 |
100.00%
|
Dec. 31, 2023 | USD 9.91 | -0.63% |
|
Italy |
|
42 |
100.00%
|
Dec. 31, 2023 | USD 2.74 | 1.67% |
|
Sweden |
|
43 |
100.00%
|
Dec. 31, 2023 | USD 0.77 | -0.80% |
|
Norway |
|
44 |
100.00%
|
Dec. 31, 2023 | USD 1.80 | 1.12% |
|
China |
|
45 |
100.00%
|
Dec. 31, 2023 | USD 0.23 | 0.44% |
|
Norway |
|
46 |
100.00%
|
Sept. 30, 2024 | USD 4.26 | 4.41% |
|
United States |
|
47 |
100.00%
|
June 30, 2024 | USD 0.03 | -4.36% |
|
United Kingdom |
|
48 |
100.00%
|
June 30, 2024 | USD 0.74 | -1.40% |
|
Australia |
|
49 |
100.00%
|
Dec. 31, 2023 | USD 0.19 | -0.67% |
|
Israel |
|
50 |
100.00%
|
June 30, 2024 | USD 1.53 | 1.32% |
|
Australia |
The Pharmaceuticals company with the highest Gross Profit Margin is Alzinova AB (publ) (Stockholm Stock Exchange: ALZ.ST) at 7,360.74%.
The Pharmaceuticals company with the lowest Gross Profit Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,970,400.00%.
The top 10 Pharmaceuticals companies the Global by Gross Profit Margin are Alzinova AB (publ), MPH Health Care AG, Iconovo AB (publ), CARBIOTIX AB, Nanexa AB (publ), Avalo Therapeutics, Inc., Kontigo Care AB (publ), Aelis Farma SA, Nanobiotix S.A. and iBio, Inc..
The bottom 10 Pharmaceuticals companies by Gross Profit Margin are Inhibikase Therapeutics, Inc., Molecure S.A., Allogene Therapeutics, Inc., InMed Pharmaceuticals Inc., FunPep Company Limited, Genomtec S.A., Checkpoint Therapeutics, Inc., Revolution Medicines, Inc., Chimerix, Inc. and PureTech Health plc.